These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2766855)

  • 1. Influence of environmental factors on the in vitro efficacy of ciprofloxacin against anaerobic bacteria.
    Thadepalli H; Bansal MB; Marshall R; Prabhala RH
    Chemotherapy; 1989; 35(3):153-9. PubMed ID: 2766855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.
    Bansal MB; Thadepalli H
    Antimicrob Agents Chemother; 1987 Apr; 31(4):619-21. PubMed ID: 3606066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
    Borobio MV; Perea EJ
    Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is ciprofloxacin active against clinically important anaerobes?
    Watt B; Brown FV
    J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
    Esposito S; Gupta A; Thadepalli H
    Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of ciprofloxacin combined with flomoxef against Bacteroides fragilis, compared with that of ciprofloxacin combined with clindamycin.
    Kato K; Iwai S; Sato T; Harada T; Nakagawa Y; Iwanaga H; Ito Y; Takayama T
    J Infect Chemother; 2002 Jun; 8(2):190-3. PubMed ID: 12111577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial spectrum of Win 49375.
    Jacobus NV; Tally FP; Barza M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):104-7. PubMed ID: 6476813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pH on antibiotics used to treat anaerobic infection.
    Winstanley TG; Wilcox MH; Spencer RC
    J Antimicrob Chemother; 1992 May; 29(5):594-5. PubMed ID: 1320606
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.
    Borobio MV; Pascual A; Dominguez MC; Perea EJ
    Antimicrob Agents Chemother; 1986 Oct; 30(4):626-7. PubMed ID: 3466569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.
    Genzel GH; Stubbings W; Stîngu CS; Labischinski H; Schaumann R
    Int J Antimicrob Agents; 2014 Nov; 44(5):420-3. PubMed ID: 25264128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of ciprofloxacin against anaerobic bacteria.
    Sutter VL; Kwok YY; Bulkacz J
    Antimicrob Agents Chemother; 1985 Mar; 27(3):427-8. PubMed ID: 3158278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
    Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria.
    Fernandes PB; Shipkowitz N; Bower RR; Jarvis KP; Weisz J; Chu DT
    J Antimicrob Chemother; 1986 Dec; 18(6):693-701. PubMed ID: 3818495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro effect of piperacillin, amoxicillin, cefoxitin and metronidazole against obligate anaerobic bacteria].
    Derriennic M; Reynaud A; Launay C; Courtieu AL
    Presse Med; 1986 Dec; 15(46):2279-81. PubMed ID: 2949268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
    Dubreuil L; Devos J; Beerens H; Romond C
    Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo-Martínez MJ
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.